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Background: Occult biliary disease has been suggested as a frequent underlying cause of idiopathic
acute pancreatitis (IAP). Cholecystectomy has been proposed as a strategy to prevent recurrent IAP.
The aim of this systematic review was to determine the efficacy of cholecystectomy in reducing the risk
of recurrent IAP.
Methods: PubMed, Embase and Cochrane Library databases were searched systematically for studies
including patients with IAP treated by cholecystectomy, with data on recurrence of pancreatitis. Studies
published before 1980 or including chronic pancreatitis and case reports were excluded. The primary
outcome was recurrence rate. Quality was assessed using the Newcastle–Ottawa Scale. Meta-analyses
were undertaken to calculate risk ratios using a random-effects model with the inverse-variance method.
Results: Overall, ten studies were included, of which nine were used in pooled analyses. The study
population consisted of 524 patients with 126 cholecystectomies. Of these 524 patients, 154 (29⋅4 (95
per cent c.i. 25⋅5 to 33⋅3) per cent) had recurrent disease. The recurrence rate was significantly lower
after cholecystectomy than after conservative management (14 of 126 (11⋅1 per cent) versus 140 of 398
(35⋅2 per cent); risk ratio 0⋅44, 95 per cent c.i. 0⋅27 to 0⋅71). Even in patients in whom IAP was diagnosed
after more extensive diagnostic testing, including endoscopic ultrasonography or magnetic resonance
cholangiopancreatography, the recurrence rate appeared to be lower after cholecystectomy (4 of 36 (11
per cent) versus 42 of 108 (38⋅9 per cent); risk ratio 0⋅41, 0⋅16 to 1⋅07).
Conclusion: Cholecystectomy after an episode of IAP reduces the risk of recurrent pancreatitis. This
implies that current diagnostics are insufficient to exclude a biliary cause.
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Introduction
Acute pancreatitis is an increasing healthcare problem1
with a wide range of causes. A biliary cause is found in
approximately half of patients, followed by alcohol con-
sumption in approximately 20 per cent and less com-
mon causes such as medication, hypertriglyceridaemia and
autoimmune diseases. In as many as one-third of patients,
the aetiology of acute pancreatitis remains unknown (ini-
tially), and the disease is referred to as idiopathic acute
pancreatitis (IAP)2,3.
Numerous studies have suggested that microlithiasis and
sludge might cause a large subset of IAP4,5. Small stones
(less than 4mm), usually referred to as microlithiasis6, and
sludge are often difficult to detect by transabdominal ultra-
sound imaging, especially if located in the common bile
duct (CBD). Therefore, in daily practice, many patients
who are initially thought to have IAP may, in fact, have
biliary pancreatitis. Gallstones, microlithiasis and sludge
are all considered as potential biliary causes of pancre-
atitis. To reduce the risk of recurrent acute pancreatitis,
same-admission cholecystectomy is advised for mild biliary
pancreatitis7.
Some studies8,9 have advised cholecystectomy after acute
pancreatitis if no other aetiology can be found implying
the diagnosis of IAP during evaluation. However, the
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work-up for a potential biliary cause in these studies was
incomplete. Endoscopic ultrasound imaging (EUS), which
has been shown to detect a biliary aetiology in one-third
of patients with IAP, and, to a lesser extent, magnetic
resonance cholangiopancreatography (MRCP), were often
not done10.
The primary aim of this systematic review was to deter-
mine the efficacy of cholecystectomy in reducing the recur-
rence rate of pancreatitis in patients with IAP. Patients with
presumed IAP and those in whom IAP remained the most
likely diagnosis after extensive evaluation were analysed
separately.
Methods
This review was written in accordance with PRISMA11 and
MOOSE guidelines12, and was registered in the PROS-
PERO database (CRD42017055275).
Definitions
Data were analysed based on the definitions of IAP as
outlined in the original articles, and according to cur-
rent guidelines13, which define IAP as acute pancreatitis in
which no aetiology can be determined by standard diag-
nostic evaluation, consisting of a detailed history, labora-
tory serum tests (liver enzymes, calcium and triglycerides)
and imaging (transabdominal ultrasonography on admis-
sion and repeated after discharge).
Three types of IAP were defined for the purposes of this
study. First, ‘original’ IAP was defined in accordance with
definitions used in the original articles. Second, ‘presumed’
IAPwas defined by diagnosis of IAP after the standard eval-
uation. Third, ‘true’ IAP was defined as an acute pancreati-
tis episode that remained unexplained after both standard
diagnostic work-up and additional diagnostic tests such as
EUS and MRCP (Fig. 1).
Outcome measures
The primary outcome was recurrence rate of acute pancre-
atitis, calculated as the proportion of patients experienc-
ing one or multiple episodes of recurrent acute pancreatitis
after an index episode of ‘original’, ‘presumed’ or ‘true’ IAP.
Secondary outcomes were complications of cholecystec-
tomy, severity of recurrences as defined by the revised
Atlanta classification14, and occurrence of biliary events
before cholecystectomy.
Search strategy
Guided by an experienced librarian, the PubMed,
Embase and Cochrane Library databases were searched
systematically for relevant articles published between
inception and 1 September 2018 (Appendix S1, supporting
information). Search terms included ‘pancreatitis’, ‘idio-
pathic’ and ‘cholecystectomy’. Studies of adult humans
in English were considered. Duplicates were removed
and the search results were recorded using the Covidence
systematic review software (Veritas Health Innovation,
Melbourne, Victoria, Australia).
Study selection
Two reviewers screened potentially relevant articles inde-
pendently by examining the titles and abstracts. Studies
were included if they fulfilled the following criteria: the
study cohort comprised patients with IAP; the interven-
tion was cholecystectomy and the comparator conservative
treatment; and the outcome was rates of recurrent acute
pancreatitis. Exclusion criteria were: letters, comments,
case reports, reviews, conference abstracts, book chapters,
studies not written in English, and studies published
before 1980, owing to discrepancies in diagnostic evalua-
tion before 1980 compared with current state-of-the-art
work-up.
The two reviewers read the full text of potentially eligible
studies individually. The reference lists of included articles
were screened for relevant publications not identified by
the initial search. Disagreements regarding eligibility were
resolved after joint re-evaluation by the two reviewers.
Data extraction
After selecting studies that met the inclusion criteria, all
relevant data from these studies were extracted by two
reviewers using a standard form. Relevant data included:
study characteristics (authors, years of inclusion, publi-
cation year, country, study design, number of patients,
duration of follow-up), patient characteristics (sex, age,
recurrent or first episode of pancreatitis, number of pre-
vious attacks, severity of pancreatitis, previous cholecys-
tectomy), diagnostic evaluation (history, laboratory tests,
imaging), interventions (cholecystectomy) and outcome
measures. No attempt was made to communicate with the
corresponding authors concerning missing data. Missing
information was registered as ‘not reported’ and studies
with missing data were excluded from subsequent pooled
analyses.
Quality assessment
Two reviewers appraised the quality of the included stud-
ies independently using the Newcastle–Ottawa Scale for
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Fig. 1 Diagnostic process and definitions
‘Original’ IAP
 All patients considered to have
 idiopathic disease according to
 definitions in original articles
‘Presumed’ IAP
 Patients considered to have
 idiopathic disease after standard
 diagnostic evaluation according to
 current guidelines
‘True’ IAP
 Patients considered to have
 idiopathic disease after additional
 diagnostic tests
Aetiology determined
during standard
diagnostic evaluation
according to current
guidelines
Standard evaluation
 Personal history (previous acute
 pancreatitis, known gallstone
 disease, alcohol intake, medication
 and drug intake, known
 hyperlipidaemia, trauma, recent
 invasive procedures such as ERCP)
 Family history of pancreatic disease
 Laboratory serum tests (liver
 enzymes, calcium, triglycerides)
 Imaging (right upper quadrant
 ultrasonography on admission and
 after discharge)
Additional diagnostic tests
 CT
 Diagnostic ERCP
 Bile examination
 EUS
 MRCP
No additional diagnostic
tests
Aetiology determined
during additional
diagnostic tests
IAP, idiopathic acute pancreatitis; ERCP, endoscopic retrograde cholangiopancreatography; EUS endoscopic ultrasonography;MRCP, magnetic resonance
cholangiopancreatography.
cohort studies15. In tailoring the scale for the purpose of
this review, presence of sludge as an exclusion criterion for
the intervention and comparator groups was considered
to be the most important factor indicating comparability
between these groups. Other relevant factors were CBD
width, raised serum alanine aminotransferase (ALT) levels,
and cholecystectomy before index admission. Follow-up of
at least 2 years was considered to be adequate for recurrence
to have occurred. Loss to follow-up exceeding 10 per cent
was considered likely to introduce bias. Disagreement was
resolved after discussion between the two reviewers.
Statistical analysis
Study characteristics, patient characteristics, use of diag-
nostic tests, treatment with cholecystectomy and secondary
outcome measures were reported descriptively.
Pooled recurrence rates from the included studies were
reported as proportions and percentages, with two-sided
95 per cent confidence intervals. Recurrence rates were
pooled in meta-analysis using a random-effects model with
the inverse-variance method to calculate risk ratios with 95
per cent confidence intervals. Subgroup analyses of patients
with ‘presumed’ IAP and ‘true’ IAP were undertaken. Sta-
tistical between-study heterogeneity was assessed using the
I2 statistic. I2 values of less than 25 per cent, 25–49 per
cent, 50–75 per cent and more than 75 per cent were con-
sidered to indicate low, moderate, high and very high lev-
els of heterogeneity respectively16. To evaluate publication
bias, a funnel plot was created using Egger’s linear regres-
sion method17,18.
Results
Study selection
From PubMed (268 records), Embase (711) and Cochrane
Library (28) searches, with additional records iden-
tified through screening of reference lists (288), ten
articles were selected for inclusion in the qualitative
analysis. One case–control study19 included a highly
selected group of 23 patients who eventually underwent
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Fig. 2 PRISMA flow chart showing selection of articles for review
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cholecystectomy. Considering potential selection bias, this
study was excluded from the quantitative analyses, leaving
nine studies in the meta-analyses (Fig. 2).
Study characteristics
Among the ten included studies, there was one RCT8,
one cross-sectional study20, six prospective cohort
studies4,5,21–24 and two9,19 retrospective cohort studies
(Table 1). The only RCT8 compared cholecystectomy with
conservative treatment in 85 patients with IAP, with an
allocation ratio of 1 : 1. The person enrolling patients in
the trial was blinded to the treatment allocation, before
block randomization. Patients, physicians and researchers
were not blinded. EUS was not used in this RCT, which
enrolled patients between January 2009 and January 2013.
Patient characteristics
In total, 901 patients with acute pancreatitis were included.
Among these patients, the cause was biliary in 325,
alcoholic in 16, known but unspecified in ten24, hyper-
lipidaemia in two and a duodenal duplication cyst in one
patient. A total of 547 patients were considered to have
‘original’ IAP. Of these, 23 patients were included in one
case–control study19 and were excluded from further
analyses, leaving 524 patients with ‘original’ IAP in the
meta-analysis.
Six cohorts5,19–21,23,24 included patients with recurrent
IAP, whereas three studies4,9,22 did not report this. Only
one study8 excluded patients with a recurrent episode of
‘presumed’ IAP (Table 2).
Critical appraisal
Most of the studies scored 320,24, 45,21–23 or 54,19 of a
maximum of 9 points on the Newcastle–Ottawa Scale.
One study9 scored 6 points and the RCT8 scored 8
points. Nearly all studies had trouble ensuring compa-
rability between cohorts. Only one study19 controlled
for the presence of sludge, raised liver enzyme levels
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Table 1 Characteristics of included studies
Reference Inclusion period Country Study design No. of patients Follow-up (months)*
Lee et al.4 1980–1988 New Zealand, USA Prospective cohort study 86 48 (6–84)
Pérez-Martín et al.20 1994–1996 Spain Observational transverse cohort study 18 n.r.
Liu et al.22 1996–1997 China Prospective cohort study 89 22†
Tandon and Topazian24 n.r. USA Post hoc analysis of prospective database 41 16 (4–44)
Saraswat et al.21 n.r. India Prospective cohort study 24 30 (4–48)
Garg et al.5 1995–2003 India Prospective cohort study 75 17⋅6 (1–156)
Ortega et al.23 2005–2009 Spain Prospective cohort study 49 16(9)‡
Trna et al.19 1990–2005 USA Retrospective case–control study 239 99 (8–220)†
Räty et al.8 2009–2013 Finland RCT 85 36 (5–58)†
Stevens et al.9 2005–2015 Australia Retrospective cohort study 195 50 (6)§
*Values are mean (range) unless indicated otherwise; values are †median (range), ‡mean(s.d.) and §mean (minimum). n.r., Not reported.
Table 2 Characteristics of included patients with idiopathic acute pancreatitis
Reference
No. of
patients
with IAP Male Age (years)*
Recurrent
pancreatitis
No. of previous
attacks*
Severe
pancreatitis
Previous
cholecystectomy
Lee et al.4 29§ 16 (55) 53 (31–79) n.r. n.r. n.r. 0 (0)
Pérez-Martín et al.20 18 8 (44) 54 5 (28) 1 (4 patients) and 3
(1 patient)
4 (22)¶ 0 (0)
Liu et al.22 18 9 (50) 68 (24–86)† n.r. n.r. n.r. 0 (0)
Tandon and Topazian24 31 12 (39) 48⋅8 (19–87) 17 (55) 44 in 17 patients n.r. 3 (10)
Saraswat et al.21 24 4 (17) 36 (18–56) 24 (100) 4 or more n.r. 0 (0)
Garg et al.5 75 60 (80) 31⋅9 (14–67) 75 (100) 4⋅82 (2–10) n.r. n.r.
Ortega et al.23 49 24 (49) 58(17)‡ 16 (33) n.r. 5 (10)# 9 (18)
Trna et al.19 23 10 (43) n.r. 8 (35) 2 (6 patients) and 3
(2 patients)
n.r.** 0 (0)
Räty et al.8 85 52 (61) Intervention group 56†
Control group 57†
0 (0) – 4 (5)†† 0 (0)
Stevens et al.9 195 100 (51⋅3) 54 (15–93)† n.r. n.r. n.r. 0 (0)
Total 547 295 (53⋅9) – 145 – 13 12
Values in parentheses are percentages unless indicated otherwise; *values are mean (range), except †median (range) and ‡mean(s.d.). §Two of 31 patients
initially considered to have idiopathic acute pancreatitis (IAP) were later found to have a dilated common bile duct on CT and endoscopic retrograde
cholangiopancreatography, and subsequently excluded from analysis. ¶Based on Ranson criteria. #Based on Atlanta classification. **Trna et al. reported 40
patients with severe pancreatitis in the entire cohort but did not specify severity in IAP subgroup. ††Based on revised Atlanta classification. n.r., Not
reported.
and cholecystectomy before index admission (Fig. S1 and
Table S1, supporting information). A funnel plot of the
included studies showed a symmetrical plot, making pub-
lication bias highly unlikely (Figs S2 and S3, supporting
information).
Diagnostic evaluation
The definition of IAP varied widely among the included
studies. None of the studies reported use of standard
diagnostic work-up as described in the International Asso-
ciation of Pancreatology/American Pancreatic Association
guideline13 to determine the most likely aetiology. Most
notably, definitions of alcoholic and biliary aetiology
varied broadly between studies (Table S2, supporting
information). Two studies19,21 excluded patients based on
raised levels of liver enzymes. Although all studies consid-
ered cholelithiasis on imaging to be an exclusion criterion
for IAP, four19,21,23,24 did not require ultrasonography in all
patients or did not mention which imaging modality was
used. One study9 included patients with raised ALT levels,
and another8 included patients with raised levels of liver
enzymes, but only if MRCP was negative for CBD stones.
Only five studies considered CBD dilatation4,20 or pres-
ence of biliary sludge on imaging5,9,20,24 to be indicative
of biliary aetiology. One study9 reported explicitly on the
presence of biliary sludge on transabdominal ultrasound
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imaging, but chose to consider this as indicative of IAP.
Repeat transabdominal ultrasonography was commonly
employed; five studies4,5,8,20,21 used it in all included
patients, and two22,24 in part of the cohort.
Eighteen of the 524 patients (3⋅4 per cent) with
‘original’ IAP appeared to have a demonstrable aeti-
ology after review of the results of standard work-up;
the disease was classified as ‘presumed’ IAP in
the remaining 506 patients. Additional diagnostic
testing comprised CT4,5,8,22,24, endoscopic retrograde
cholangiopancreatography4,5,21,22,24, microscopic bile
examination4,5,20,21,23,24, EUS5,22–24 and MRCP8,9,23,24.
Additional diagnostic tests demonstrated biliary disease in
25⋅8 per cent (111 patients), chronic pancreatitis in 15⋅2
per cent (47; although only 1 study23 reported diagnostic
criteria for chronic pancreatitis), pancreatic divisum in 3⋅9
per cent (12), neoplasms in 1⋅3 per cent (4) and ascariasis,
choledochal cyst and choledochocele in 0⋅3 per cent (1).
In total, a previously unknown potential cause of acute
pancreatitis was found using additional tests in 165 patients
(32⋅6 per cent) (Table S3, supporting information).
Cholecystectomy
Of 524 patients with ‘original’ IAP, 126 (24⋅0 per cent)
underwent cholecystectomy during follow-up. To create
a subgroup of patients with ‘true’ IAP, several groups of
patients were excluded: those in whom an aetiology was
established during either standard (18) or additional (165)
work-up, those for whom it was not sufficiently reported
whether biliary disease was present (195)9 and patients in
whom the disease course during follow-up was unclear
(2)23. In the subgroup of 144 patients with ‘true’ IAP, 36
cholecystectomies (25⋅0 per cent) were performed (Fig. S4,
supporting information).
One study8 also reported pathology results for the gall-
bladder. Microlithiasis was observed on pathological exam-
ination in 23 of 39 gallbladders.
Complications of cholecystectomy
One study9 reported one bile duct injury in 66 cholecys-
tectomies, and two studies8,22 reported no complications
in 13 and 39 cholecystectomies respectively. In total, there
was one complication in 118 cholecystectomies (0⋅8 (95 per
cent c.i. 0 to 2⋅5) per cent). Cholecystectomy complication
rates were not reported in the remaining studies.
Recurrence
Of the 524 patients with ‘original’ IAP, 154 had at least one
recurrence during follow-up (29⋅4 (95 per cent c.i. 25⋅5 to
33⋅3) per cent). Meta-analysis of this group showed that
the recurrence rate among patientsmanaged conservatively
was significantly higher than that in patients who under-
went cholecystectomy (140 of 398 (35⋅2 per cent) versus
14 of 126 (11⋅1 per cent); risk ratio 0⋅44, 95 per cent c.i.
0⋅27 to 0⋅71) (Fig. S5, supporting information). Similarly,
in the subgroup of 506 patients with ‘presumed’ IAP, the
recurrence rate was higher among patients who received
conservative treatment (139 of 387 (35⋅9 per cent) versus 14
of 119 (11⋅8 per cent); risk ratio 0⋅45, 0⋅28 to 0⋅73) (Fig. 3).
Fig. 3 Pooled analysis of recurrence of pancreatitis in patients with ‘presumed’ idiopathic acute pancreatitis treated with cholecystec-
tomy versus conservative management
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Liu et al.22
Tandon and Topazian24
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Heterogeneity: τ2= 0·00; χ2= 1·93, 7 d.f., P = 0·96; I2= 0%
Test for overall effect: Z = 3·29, P = 0·001
Risk ratios are shown with 95 per cent confidence intervals. A random-effects inverse-variance model was used for meta-analysis.
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Fig. 4 Pooled analysis of recurrence of pancreatitis in patients with ‘true’ idiopathic acute pancreatitis treated with cholecystectomy
versus conservative management
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Risk ratios are shown with 95 per cent confidence intervals. A random-effects inverse-variance model was used for meta-analysis.
Among 144 patients with ‘true’ IAP, 46 had at least one
recurrence during follow-up (31⋅9 (30⋅8 to 46⋅8) per cent).
In pooled analysis, the recurrence rate was 11 per cent (4 of
36) in the cholecystectomy group and 38⋅9 per cent (42 of
108 patients) in the conservative treatment (risk ratio 0⋅41,
0⋅16 to 1⋅07) (Fig. 4).
There was no statistical between-study heterogeneity in
any of the pooled analyses (I2 = 0 per cent).
None of the included studies reported severity of
recurrences.
Biliary events before cholecystectomy
The occurrence of biliary events (cholecystitis, biliary
colic, obstructive choledocholithiasis, biliary pancreatitis
and cholangitis) was not reported systematically. Three
studies briefly mentioned biliary events before cholecys-
tectomy. One study22 reported no biliary events, and
another20 reported one patient with a recurrent episode
of acute (biliary) pancreatitis, after which cholecystectomy
was performed. The third study4 reported 13 patients with
recurrent episodes of biliary pancreatitis, five of whom
were treated by cholecystectomy and three by endoscopic
sphincterotomy.
Discussion
This systematic review and meta-analysis showed that
cholecystectomy might reduce the risk of recurrence of
IAP. This effect appeared to be independent of the eval-
uation before making the diagnosis of IAP.
The efficacy of cholecystectomy in preventing biliary
events after biliary pancreatitis is undisputed7. The results
of this review are therefore in line with the theory that a
significant number of patients with ‘presumed’ and ‘true’
IAP actually have biliary pancreatitis. This is exemplified by
the high rate of microlithiasis on pathological examination
of the gallbladder8. Previous research10 has suggested that
additional diagnostic work-up with EUS and MRCP may
detect a biliary cause in patients with IAP, after negative
transabdominal ultrasonography and biochemical tests. In
the present study, however, the impact of cholecystectomy
in reducing recurrence of acute pancreatitis appeared to be
independent of the preoperative evaluation, either includ-
ing or excluding MRCP and EUS. Possible explanations
for this are the suboptimal sensitivity of MRCP for the
detection of sludge and lack of a standardized approach
to EUS.
Another intriguing finding is the larger number of other
pancreatic disorders observed in the included studies, apart
from biliary disease. Most notably, chronic pancreatitis was
diagnosed in 15⋅2 per cent and neoplasms in 1⋅3 per cent.
Additionally, pancreas divisum was found in 12 patients
(3⋅9 per cent), although a causative relationship between
pancreas divisum and acute pancreatitis is debated25.
The present results should be interpreted in light of sev-
eral shortcomings. First, most of the included studies were
small in size, especially the subgroup of the 144 patients
with ‘true’ IAP, in whom only 36 cholecystectomies were
performed. This subgroup analysis showed no significant
difference in recurrence rate after cholecystectomy, possi-
bly owing to insufficient sample size.
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Second, there was heterogeneity between studies as some
included both patients with a first episode of IAP and
those with recurrent IAP, and definitions of IAP differed
across studies. Partly owing to evolving insights regarding
work-up of IAP and availability of diagnostic tests, many
of the included studies did not undertake complete stan-
dard and additional diagnostic testing according to current
international guidelines13. This may have led to the inclu-
sion of patients in whom a biliary aetiology could have been
demonstrated if standard and additional diagnostic tests
had been carried out properly. Including those in whom
biliary disease went undiagnosed may have led to overesti-
mation of the effect of cholecystectomy in IAP.
Third, only one study8 had a randomized design, but this
trial was not sham-controlled and the patients were not
blinded. Undergoing surgery may influence the patient’s
lifestyle, and previous literature26 has shown that cessation
of alcohol and nicotine use are particularly effective in
preventing recurrence.
Fourth, cholecystectomy was almost always undertaken
only in patients with proven biliary disease after additional
investigation. Only one study23 that performed EUS, and
one8 that performed MRCP if indicated in 28 patients,
undertook cholecystectomies in patients with ‘true’ IAP
(Fig. 4). This confounding by indication creates a clear
overestimation of the effect of cholecystectomy. In the
most relevant subgroup studied in this review, patients with
‘true’ IAP, this overestimation is reduced to an important
extent.
Future studies should address discrepancies in defining
IAP as opposed to biliary pancreatitis. Reaching interna-
tional consensus regarding the criteria for diagnosis of aeti-
ologies is desirable, and would facilitate unambiguity in
research as well as in clinical practice. A guideline-based
proposal of such criteria is provided in Fig. S6 (supporting
information). Future studies in IAP should also focus on
patients with either a first episode of IAP or recurrent pan-
creatitis, as these two groups appear to have distinct disease
courses and should be considered as separate entities27.
This review has shown that cholecystectomy could
potentially reduce the recurrence rate in patients diagnosed
with ‘true’ IAP. However, the results for this subgroup
were not statistically significant, probably because of the
relatively small sample size. Thus, there appears to be some
merit in treating IAP pragmatically by cholecystectomy
to prevent recurrence, as suggested in previous studies8,9.
On the other hand, with further standardization and
improvement of diagnostic work-up, it should be possible
to identify most patients with biliary aetiology. The wide
variety of aetiologies revealed by additional investigation
in the included studies underlines the value of additional
diagnostic tests, at least in recurrent idiopathic pancreati-
tis. More research is needed to determine the importance
of routine additional diagnostic work-up and to establish
whether the yield of extra information could outweigh
the efficacy of a pragmatic cholecystectomy in preventing
recurrence.
The present review supports the hypothesis that many
patients with IAP have occult biliary disease by showing
an apparent reduction in recurrence after cholecystectomy
in patients in whom no additional preoperative biliary
diagnostics were undertaken. This underlines the need for
a more thorough evaluation before the diagnosis of IAP
can be made. Additional research is needed in patients
with ‘true’ IAP after optimal testing for biliary aetiology to
determine the efficacy of cholecystectomy in this specific
population.
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